- Home
- ARDX vs SENEB Comparison
ARDX vs SENEB Comparison
Compare ARDX & SENEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARDX
- SENEB
- Stock Information
- Founded
- ARDX 2007
- SENEB 1949
- Country
- ARDX United States
- SENEB United States
- Employees
- ARDX N/A
- SENEB N/A
- Industry
- ARDX Biotechnology: Pharmaceutical Preparations
- SENEB Packaged Foods
- Sector
- ARDX Health Care
- SENEB Consumer Staples
- Exchange
- ARDX Nasdaq
- SENEB Nasdaq
- Market Cap
- ARDX 882.9M
- SENEB 720.7M
- IPO Year
- ARDX 2014
- SENEB N/A
- Fundamental
- Price
- ARDX $5.57
- SENEB $110.57
- Analyst Decision
- ARDX Strong Buy
- SENEB
- Analyst Count
- ARDX 10
- SENEB 0
- Target Price
- ARDX $10.65
- SENEB N/A
- AVG Volume (30 Days)
- ARDX 4.4M
- SENEB 107.0
- Earning Date
- ARDX 10-30-2025
- SENEB 11-05-2025
- Dividend Yield
- ARDX N/A
- SENEB N/A
- EPS Growth
- ARDX N/A
- SENEB 47.84
- EPS
- ARDX N/A
- SENEB 8.62
- Revenue
- ARDX $398,234,000.00
- SENEB $1,606,175,000.00
- Revenue This Year
- ARDX $18.90
- SENEB N/A
- Revenue Next Year
- ARDX $31.52
- SENEB N/A
- P/E Ratio
- ARDX N/A
- SENEB $12.39
- Revenue Growth
- ARDX 58.12
- SENEB 8.33
- 52 Week Low
- ARDX $3.21
- SENEB $63.00
- 52 Week High
- ARDX $6.78
- SENEB $116.97
- Technical
- Relative Strength Index (RSI)
- ARDX 52.45
- SENEB 62.42
- Support Level
- ARDX $5.59
- SENEB $110.96
- Resistance Level
- ARDX $6.73
- SENEB $112.30
- Average True Range (ATR)
- ARDX 0.30
- SENEB 0.24
- MACD
- ARDX 0.09
- SENEB -0.60
- Stochastic Oscillator
- ARDX 35.44
- SENEB 69.01
About ARDX Ardelyx Inc.
Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. It product Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.
About SENEB Seneca Foods Corp. Class B
Seneca Foods Corp is a US-based company which acts as a provider of packaged fruits and vegetables. Its product offerings include canned, frozen, and bottled produce and snack chips. The company's segment includes Vegetable and Fruit/Snack. It generates maximum revenue from the Vegetable segment.